Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...
Q4 2025 Earnings Call February 27, 2026 4:30 AM ESTCompany ParticipantsJohan Svanstrom - CEO & Executive DirectorRuaridh Hook ...
We have been familiar with 5G for quite some time, which may lead you to wonder whether 6G is already taking shape. Nothing could be further from the truth, as it turns out.
Astronomers with the Hobby-Eberly Telescope Dark Energy Experiment (HETDEX) have used data from the project to make the ...
Carla Tardi is a technical editor and digital content producer with 25+ years of experience at top-tier investment banks and money-management firms. Khadija Khartit is a strategy, investment, and ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results